Werewolf Therapeutics, Inc.

Werewolf Therapeutics, Inc.: 1 tracked 2026 layoff event(s), 0 workers counted, highest AI score 7.

7

2026-02-13 · Not stated in 8-K

AI score 7 (80% interval 5–8) · evidence grade D · US · Pharma / Chemicals

Stated reason: On February 9, 2026, the board of directors (the “Board”) of Werewolf Therapeutics, Inc. (the “Company”) approved a reduction in force, representing 64% of the Company’s workforce (the “Reduction”). The Company expects the Reduction to be substantially completed by February 13, 2026. The Company is undertaking the Reduction to decrease operating expenses. As a result of the Reduction, the Company estimates that it wi…

Why 7: Cost-cutting / efficiency · Drivers: industry AI exposure +0.5, role AI exposure +0.2

Signals: attribution 0.0, primary 0.0, exec 0.0, role exposure 0.837, industry exposure 0.712, AI investment 0.0, contrary 0.0 · named roles: Computer Systems Analysts, Computer and Information Systems Managers, Data Scientists, General and Operations Managers, Software Developers

Headcount basis: not disclosed

Sources (4)

Company AI financials (AI spending, revenue, earnings-call AI mentions) are coming soon to this page.